Cabot Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
BIT
Cabot Wealth Management's BMY Position: Q2 2015 in Review
Cabot Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2015, closing a stake of 19,520 shares — an estimated $1.26M sold.
Cabot Wealth Management first reported a position in BMY in Q2 2013 and held it in 8 quarters. The position peaked at $1.26M in Q1 2015. 1,447 funds tracked by Wall St. Rank hold BMY as of Q2 2015.
- Cabot Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2015 after selling out during the quarter.
- Cabot Wealth Management sold 19,520 Bristol-Myers Squibb shares in Q2 2015, an estimated $1.26M.
- Cabot Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 8 quarters.
- Cabot Wealth Management's Bristol-Myers Squibb position peaked at $1.26M in Q1 2015.
- 1,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2015.
Based on Cabot Wealth Management's 13F filing for Q2 2015, filed 7 Aug 2015.